Cargando…
Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor – Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific Region
Although gastroesophageal reflux disease is not as common in Asia as in western countries, the prevalence has increased substantially during the past decade. Gastroesophageal reflux disease is associated with considerable reductions in subjective well-being and work productivity, as well as increase...
Autores principales: | Goh, Khean Lee, Choi, Myung Gyu, Hsu, Ping I, Chun, Hoon Jai, Mahachai, Varocha, Kachintorn, Udom, Leelakusolvong, Somchai, Kim, Nayoung, Rani, Abdul Aziz, Wong, Benjamin C Y, Wu, Justin, Chiu, Cheng Tang, Shetty, Vikram, Bocobo, Joseph C, Chan, Melchor M, Lin, Jaw-Town |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930293/ https://www.ncbi.nlm.nih.gov/pubmed/26932927 http://dx.doi.org/10.5056/jnm15150 |
Ejemplares similares
-
Phase 4 Study in Patients From Asia With Gastroesophageal Reflux Disease Treated With Dexlansoprazole
por: Wu, Justin C Y, et al.
Publicado: (2020) -
Managing gastroesophageal reflux disease – comparative efficacy and outcomes of dexlansoprazole MR
por: Frye, Jeanetta W, et al.
Publicado: (2015) -
Pharmacokinetics and safety of dexlansoprazole MR in pediatric patients with symptomatic gastroesophageal reflux disease
por: Kukulka, Michael, et al.
Publicado: (2014) -
Thailand guideline 2020 for medical management of gastroesophageal reflux disease
por: Maneerattanaporn, Monthira, et al.
Publicado: (2022) -
Diagnosis and Management of Gastroesophageal Reflux Disease
por: Hsu, Ping-I, et al.
Publicado: (2013)